Daniel Olive

This inventor holds 28 USPTO granted patents and 31 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Antibody Therapeutics. Top assignees: National Institute of Health and Medical Research, Université´ D'aix-Marseille, Institut Jean Paoli & Irène Calmettes. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Olive. Retrieved from https://idiyas.com/inventor/daniel-olive

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 31)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 17)

EPO Patents = 13 (Patent Applications = 49)

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 139(Granted Patents)

Company Filing History:

25 out of 1,853

National Institute of Health and Medical Research

patents

21 out of 237

Université´ D'aix-Marseille

patents

19 out of 32

Institut Jean Paoli & Irène Calmettes

patents

4. 11 out of 5,383

Centre National De La Recherche Scientifique

University Claude Bernard - Lyon 1

patents

7. 4 out of 4

Imcheck Therapeutics Sas

patents

8. 2 out of 156

The University of Nantes

patents

9. 1 out of 4,517

Eli Lilly and Company

patents

10. 1 out of 1

Emergence Therapeutics Gmbh

Universite Aix-Marseille

patents

13. 1 out of 10

Université Claude Bernard

patents

14. 1 out of 1

Universite Claude Bernerd—lyon }

patent

15. 1 out of 8

Université De La Méditerranée

patents

16. 4 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugate

Nectin-4

BTN3A

ICOS

Cancer Treatment

Graft-Versus-Host Disease

PD-1

PD-L1

Hematologic Malignancies

Therapeutic Antibodies

BTLA

CD28

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419964 - Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload (2025-09-23),

2. 12398206 - Antibodies having specificity for nectin-4 and uses thereof (2025-08-26),

3. 12258400 - Antibodies having specificity for BTN2 and uses thereof (2025-03-25),

4. 12247075 - BTN3A binding proteins and uses thereof (2025-03-11),

5. 12049500 - Anti-nectin-4-antibodies and uses thereof (2024-07-30),

6. 11987631 - Anti-BTN3A antibodies and their use in treating cancer or infectious disorders (2024-05-21),

7. 11945871 - Anti-BTN3A antibodies and their use in treating cancer or infectious disorders (2024-04-02),

8. 11904004 - Anti-CD277 antibodies (2024-02-20),

9. 11572409 - Antibodies having specificity for BTN2 and uses thereof (2023-02-07),

10. 11180556 - Antibodies directed against ICOS and uses thereof (2021-11-23),

11. 10745482 - Antibodies directed against ICOS and uses thereof (2020-08-18),

12. 10716838 - Anti-CD277 antibodies (2020-07-21),

13. 10675357 - Antibodies having specificity to nectin-4 and uses thereof (2020-06-09),

14. 10633446 - Antibodies directed against ICOS and uses thereof (2020-04-28),

15. 10273306 - Antibodies directed against ICOS for treating graft-versus-host disease (2019-04-30),

Title: The Innovative Journey of Daniel Olive

Introduction: Daniel Olive, a visionary inventor hailing from Marseilles, FR, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Daniel Olive's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution that aims to combat climate change, and a medical device that enhances patient care in hospitals worldwide.

Career Highlights: Throughout his illustrious career, Daniel Olive has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have garnered international acclaim and have been instrumental in shaping the future of various industries.

Collaborations: Daniel Olive has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have been crucial in turning his visionary ideas into tangible products that have a lasting impact on society.

Conclusion: In conclusion, Daniel Olive's passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor in the world of technology. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape a better tomorrow.

Profile summary based on public USPTO records.